nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—Histamine H1 Receptor Antagonists—Cetirizine—allergic rhinitis	0.206	0.363	CiPCiCtD
Olopatadine—Histamine H1 Receptor Antagonists—Desloratadine—allergic rhinitis	0.206	0.363	CiPCiCtD
Olopatadine—Histamine H1 Receptor Antagonists—Diphenhydramine—allergic rhinitis	0.156	0.275	CiPCiCtD
Olopatadine—HRH1—Cetirizine—allergic rhinitis	0.0489	0.284	CbGbCtD
Olopatadine—Nortriptyline—Cyproheptadine—allergic rhinitis	0.0406	0.223	CrCrCtD
Olopatadine—Cyclobenzaprine—Cyproheptadine—allergic rhinitis	0.0345	0.189	CrCrCtD
Olopatadine—Amitriptyline—Cyproheptadine—allergic rhinitis	0.0309	0.169	CrCrCtD
Olopatadine—HRH1—Dimenhydrinate—allergic rhinitis	0.0281	0.163	CbGbCtD
Olopatadine—HRH1—Desloratadine—allergic rhinitis	0.0239	0.139	CbGbCtD
Olopatadine—HRH1—Cyproheptadine—allergic rhinitis	0.0181	0.105	CbGbCtD
Olopatadine—Doxepin—Diphenhydramine—allergic rhinitis	0.0174	0.0954	CrCrCtD
Olopatadine—Cyclobenzaprine—Diphenhydramine—allergic rhinitis	0.0164	0.0897	CrCrCtD
Olopatadine—Dimetindene—Diphenhydramine—allergic rhinitis	0.0159	0.0871	CrCrCtD
Olopatadine—Amitriptyline—Diphenhydramine—allergic rhinitis	0.0147	0.0803	CrCrCtD
Olopatadine—HRH1—Diphenhydramine—allergic rhinitis	0.0137	0.0796	CbGbCtD
Olopatadine—HRH1—Loratadine—allergic rhinitis	0.0137	0.0796	CbGbCtD
Olopatadine—Imipramine—Diphenhydramine—allergic rhinitis	0.0122	0.0668	CrCrCtD
Olopatadine—S100A12—nose—allergic rhinitis	0.00747	0.244	CbGeAlD
Olopatadine—CYP3A4—Flunisolide—allergic rhinitis	0.00606	0.0352	CbGbCtD
Olopatadine—CYP3A4—Loratadine—allergic rhinitis	0.00348	0.0202	CbGbCtD
Olopatadine—CYP3A4—Montelukast—allergic rhinitis	0.00348	0.0202	CbGbCtD
Olopatadine—CYP3A4—Methylprednisolone—allergic rhinitis	0.00318	0.0185	CbGbCtD
Olopatadine—CYP3A4—Triamcinolone—allergic rhinitis	0.00241	0.014	CbGbCtD
Olopatadine—S100A2—exocrine gland—allergic rhinitis	0.00233	0.0762	CbGeAlD
Olopatadine—S100A1—exocrine gland—allergic rhinitis	0.00215	0.0701	CbGeAlD
Olopatadine—CYP3A4—Betamethasone—allergic rhinitis	0.00207	0.012	CbGbCtD
Olopatadine—CYP3A4—Prednisolone—allergic rhinitis	0.00204	0.0119	CbGbCtD
Olopatadine—CYP3A4—Hydrocortisone—allergic rhinitis	0.00194	0.0112	CbGbCtD
Olopatadine—HRH1—nose—allergic rhinitis	0.00151	0.0494	CbGeAlD
Olopatadine—S100A2—respiratory system—allergic rhinitis	0.00121	0.0396	CbGeAlD
Olopatadine—CYP3A4—Dexamethasone—allergic rhinitis	0.0012	0.00699	CbGbCtD
Olopatadine—S100A2—epithelium—allergic rhinitis	0.00101	0.0331	CbGeAlD
Olopatadine—S100A2—bronchus—allergic rhinitis	0.000999	0.0326	CbGeAlD
Olopatadine—S100A13—respiratory system—allergic rhinitis	0.000992	0.0324	CbGeAlD
Olopatadine—S100A12—respiratory system—allergic rhinitis	0.000979	0.032	CbGeAlD
Olopatadine—S100A2—skin of body—allergic rhinitis	0.000965	0.0315	CbGeAlD
Olopatadine—S100A1—bronchus—allergic rhinitis	0.00092	0.0301	CbGeAlD
Olopatadine—S100A13—eye—allergic rhinitis	0.000906	0.0296	CbGeAlD
Olopatadine—S100A2—trachea—allergic rhinitis	0.000897	0.0293	CbGeAlD
Olopatadine—S100A1—skin of body—allergic rhinitis	0.000889	0.029	CbGeAlD
Olopatadine—S100B—eye—allergic rhinitis	0.000882	0.0288	CbGeAlD
Olopatadine—S100A13—epithelium—allergic rhinitis	0.000829	0.0271	CbGeAlD
Olopatadine—S100A1—trachea—allergic rhinitis	0.000826	0.027	CbGeAlD
Olopatadine—S100A12—epithelium—allergic rhinitis	0.000818	0.0267	CbGeAlD
Olopatadine—S100A13—skin of body—allergic rhinitis	0.000789	0.0257	CbGeAlD
Olopatadine—S100B—skin of body—allergic rhinitis	0.000768	0.0251	CbGeAlD
Olopatadine—S100A2—lung—allergic rhinitis	0.000645	0.0211	CbGeAlD
Olopatadine—S100A13—lung—allergic rhinitis	0.000527	0.0172	CbGeAlD
Olopatadine—S100A12—lung—allergic rhinitis	0.00052	0.017	CbGeAlD
Olopatadine—S100A12—DEx/H-box helicases activate type I IFN and inflammatory cytokines production—NFKB1—allergic rhinitis	0.000243	0.0634	CbGpPWpGaD
Olopatadine—S100B—DEx/H-box helicases activate type I IFN and inflammatory cytokines production—NFKB1—allergic rhinitis	0.00023	0.06	CbGpPWpGaD
Olopatadine—HRH1—respiratory system—allergic rhinitis	0.000198	0.00647	CbGeAlD
Olopatadine—HRH1—eye—allergic rhinitis	0.000181	0.00591	CbGeAlD
Olopatadine—S100A12—RIP-mediated NFkB activation via ZBP1—NFKB1—allergic rhinitis	0.000166	0.0432	CbGpPWpGaD
Olopatadine—HRH1—epithelium—allergic rhinitis	0.000166	0.00541	CbGeAlD
Olopatadine—S100B—RIP-mediated NFkB activation via ZBP1—NFKB1—allergic rhinitis	0.000157	0.0409	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated NF-kB activation—NFKB1—allergic rhinitis	0.000149	0.0388	CbGpPWpGaD
Olopatadine—HRH1—trachea—allergic rhinitis	0.000146	0.00478	CbGeAlD
Olopatadine—S100B—TRAF6 mediated NF-kB activation—NFKB1—allergic rhinitis	0.000141	0.0367	CbGpPWpGaD
Olopatadine—S100A12—ZBP1(DAI) mediated induction of type I IFNs—NFKB1—allergic rhinitis	0.00014	0.0364	CbGpPWpGaD
Olopatadine—S100A12—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NFKB1—allergic rhinitis	0.00014	0.0364	CbGpPWpGaD
Olopatadine—S100B—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NFKB1—allergic rhinitis	0.000132	0.0345	CbGpPWpGaD
Olopatadine—S100B—ZBP1(DAI) mediated induction of type I IFNs—NFKB1—allergic rhinitis	0.000132	0.0345	CbGpPWpGaD
Olopatadine—HRH1—lung—allergic rhinitis	0.000105	0.00343	CbGeAlD
Olopatadine—Vomiting—Dimenhydrinate—allergic rhinitis	7.6e-05	0.00181	CcSEcCtD
Olopatadine—Vomiting—Diphenhydramine—allergic rhinitis	7.6e-05	0.00181	CcSEcCtD
Olopatadine—Dyspnoea—Flunisolide—allergic rhinitis	7.59e-05	0.00181	CcSEcCtD
Olopatadine—Feeling abnormal—Loratadine—allergic rhinitis	7.58e-05	0.0018	CcSEcCtD
Olopatadine—Eye pain—Dexamethasone—allergic rhinitis	7.55e-05	0.0018	CcSEcCtD
Olopatadine—Eye pain—Betamethasone—allergic rhinitis	7.55e-05	0.0018	CcSEcCtD
Olopatadine—Rash—Dimenhydrinate—allergic rhinitis	7.53e-05	0.00179	CcSEcCtD
Olopatadine—Rash—Diphenhydramine—allergic rhinitis	7.53e-05	0.00179	CcSEcCtD
Olopatadine—Dermatitis—Dimenhydrinate—allergic rhinitis	7.53e-05	0.00179	CcSEcCtD
Olopatadine—Dermatitis—Diphenhydramine—allergic rhinitis	7.53e-05	0.00179	CcSEcCtD
Olopatadine—Gastrointestinal pain—Loratadine—allergic rhinitis	7.53e-05	0.00179	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	7.52e-05	0.00179	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—MS4A2—allergic rhinitis	7.52e-05	0.0196	CbGpPWpGaD
Olopatadine—Dry skin—Prednisolone—allergic rhinitis	7.49e-05	0.00178	CcSEcCtD
Olopatadine—Headache—Diphenhydramine—allergic rhinitis	7.49e-05	0.00178	CcSEcCtD
Olopatadine—Headache—Dimenhydrinate—allergic rhinitis	7.49e-05	0.00178	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Cetirizine—allergic rhinitis	7.48e-05	0.00178	CcSEcCtD
Olopatadine—Fatigue—Cetirizine—allergic rhinitis	7.47e-05	0.00178	CcSEcCtD
Olopatadine—Pain—Cetirizine—allergic rhinitis	7.41e-05	0.00176	CcSEcCtD
Olopatadine—Fatigue—Flunisolide—allergic rhinitis	7.34e-05	0.00175	CcSEcCtD
Olopatadine—Dry skin—Hydrocortisone—allergic rhinitis	7.31e-05	0.00174	CcSEcCtD
Olopatadine—Pain—Flunisolide—allergic rhinitis	7.28e-05	0.00173	CcSEcCtD
Olopatadine—Abdominal pain—Loratadine—allergic rhinitis	7.28e-05	0.00173	CcSEcCtD
Olopatadine—Body temperature increased—Loratadine—allergic rhinitis	7.28e-05	0.00173	CcSEcCtD
Olopatadine—Oedema—Montelukast—allergic rhinitis	7.26e-05	0.00173	CcSEcCtD
Olopatadine—Infection—Montelukast—allergic rhinitis	7.21e-05	0.00172	CcSEcCtD
Olopatadine—Visual disturbance—Betamethasone—allergic rhinitis	7.19e-05	0.00171	CcSEcCtD
Olopatadine—Visual disturbance—Dexamethasone—allergic rhinitis	7.19e-05	0.00171	CcSEcCtD
Olopatadine—Feeling abnormal—Cetirizine—allergic rhinitis	7.14e-05	0.0017	CcSEcCtD
Olopatadine—Nervous system disorder—Montelukast—allergic rhinitis	7.12e-05	0.00169	CcSEcCtD
Olopatadine—S100B—Innate Immune System—MS4A2—allergic rhinitis	7.11e-05	0.0185	CbGpPWpGaD
Olopatadine—Nausea—Diphenhydramine—allergic rhinitis	7.1e-05	0.00169	CcSEcCtD
Olopatadine—Nausea—Dimenhydrinate—allergic rhinitis	7.1e-05	0.00169	CcSEcCtD
Olopatadine—Gastrointestinal pain—Cetirizine—allergic rhinitis	7.08e-05	0.00168	CcSEcCtD
Olopatadine—Skin disorder—Montelukast—allergic rhinitis	7.05e-05	0.00168	CcSEcCtD
Olopatadine—Feeling abnormal—Flunisolide—allergic rhinitis	7.02e-05	0.00167	CcSEcCtD
Olopatadine—Gastrointestinal pain—Flunisolide—allergic rhinitis	6.96e-05	0.00166	CcSEcCtD
Olopatadine—Abdominal pain—Cetirizine—allergic rhinitis	6.85e-05	0.00163	CcSEcCtD
Olopatadine—Body temperature increased—Cetirizine—allergic rhinitis	6.85e-05	0.00163	CcSEcCtD
Olopatadine—Abdominal pain—Flunisolide—allergic rhinitis	6.73e-05	0.0016	CcSEcCtD
Olopatadine—Body temperature increased—Flunisolide—allergic rhinitis	6.73e-05	0.0016	CcSEcCtD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—NFKB1—allergic rhinitis	6.64e-05	0.0173	CbGpPWpGaD
Olopatadine—Asthenia—Loratadine—allergic rhinitis	6.6e-05	0.00157	CcSEcCtD
Olopatadine—Influenza—Triamcinolone—allergic rhinitis	6.49e-05	0.00154	CcSEcCtD
Olopatadine—Somnolence—Montelukast—allergic rhinitis	6.46e-05	0.00154	CcSEcCtD
Olopatadine—Weight increased—Prednisolone—allergic rhinitis	6.43e-05	0.00153	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Hydrocortisone—allergic rhinitis	6.41e-05	0.00152	CcSEcCtD
Olopatadine—Hypersensitivity—Cetirizine—allergic rhinitis	6.38e-05	0.00152	CcSEcCtD
Olopatadine—Diarrhoea—Loratadine—allergic rhinitis	6.3e-05	0.0015	CcSEcCtD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—NFKB1—allergic rhinitis	6.28e-05	0.0164	CbGpPWpGaD
Olopatadine—Weight increased—Hydrocortisone—allergic rhinitis	6.28e-05	0.00149	CcSEcCtD
Olopatadine—Hypersensitivity—Flunisolide—allergic rhinitis	6.27e-05	0.00149	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Montelukast—allergic rhinitis	6.27e-05	0.00149	CcSEcCtD
Olopatadine—Fatigue—Montelukast—allergic rhinitis	6.26e-05	0.00149	CcSEcCtD
Olopatadine—Dry skin—Dexamethasone—allergic rhinitis	6.25e-05	0.00149	CcSEcCtD
Olopatadine—Dry skin—Betamethasone—allergic rhinitis	6.25e-05	0.00149	CcSEcCtD
Olopatadine—Asthenia—Cetirizine—allergic rhinitis	6.21e-05	0.00148	CcSEcCtD
Olopatadine—Pain—Montelukast—allergic rhinitis	6.21e-05	0.00148	CcSEcCtD
Olopatadine—Infestation NOS—Hydrocortisone—allergic rhinitis	6.15e-05	0.00146	CcSEcCtD
Olopatadine—Infestation—Hydrocortisone—allergic rhinitis	6.15e-05	0.00146	CcSEcCtD
Olopatadine—Pruritus—Cetirizine—allergic rhinitis	6.13e-05	0.00146	CcSEcCtD
Olopatadine—Conjunctivitis—Prednisolone—allergic rhinitis	6.12e-05	0.00146	CcSEcCtD
Olopatadine—Asthenia—Flunisolide—allergic rhinitis	6.11e-05	0.00145	CcSEcCtD
Olopatadine—Dizziness—Loratadine—allergic rhinitis	6.09e-05	0.00145	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Triamcinolone—allergic rhinitis	6.03e-05	0.00144	CcSEcCtD
Olopatadine—Pruritus—Flunisolide—allergic rhinitis	6.02e-05	0.00143	CcSEcCtD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—allergic rhinitis	5.99e-05	0.0156	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Montelukast—allergic rhinitis	5.94e-05	0.00141	CcSEcCtD
Olopatadine—Diarrhoea—Cetirizine—allergic rhinitis	5.93e-05	0.00141	CcSEcCtD
Olopatadine—Weight increased—Triamcinolone—allergic rhinitis	5.91e-05	0.00141	CcSEcCtD
Olopatadine—Weight increased—Methylprednisolone—allergic rhinitis	5.9e-05	0.0014	CcSEcCtD
Olopatadine—Vomiting—Loratadine—allergic rhinitis	5.85e-05	0.00139	CcSEcCtD
Olopatadine—Diarrhoea—Flunisolide—allergic rhinitis	5.83e-05	0.00139	CcSEcCtD
Olopatadine—Rash—Loratadine—allergic rhinitis	5.8e-05	0.00138	CcSEcCtD
Olopatadine—Dermatitis—Loratadine—allergic rhinitis	5.8e-05	0.00138	CcSEcCtD
Olopatadine—Infestation NOS—Methylprednisolone—allergic rhinitis	5.78e-05	0.00137	CcSEcCtD
Olopatadine—Infestation—Methylprednisolone—allergic rhinitis	5.78e-05	0.00137	CcSEcCtD
Olopatadine—Headache—Loratadine—allergic rhinitis	5.77e-05	0.00137	CcSEcCtD
Olopatadine—Abdominal pain—Montelukast—allergic rhinitis	5.74e-05	0.00137	CcSEcCtD
Olopatadine—Body temperature increased—Montelukast—allergic rhinitis	5.74e-05	0.00137	CcSEcCtD
Olopatadine—Dizziness—Cetirizine—allergic rhinitis	5.73e-05	0.00136	CcSEcCtD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—NFKB1—allergic rhinitis	5.69e-05	0.0148	CbGpPWpGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—allergic rhinitis	5.67e-05	0.0148	CbGpPWpGaD
Olopatadine—Dizziness—Flunisolide—allergic rhinitis	5.63e-05	0.00134	CcSEcCtD
Olopatadine—Conjunctivitis—Triamcinolone—allergic rhinitis	5.63e-05	0.00134	CcSEcCtD
Olopatadine—Vomiting—Cetirizine—allergic rhinitis	5.51e-05	0.00131	CcSEcCtD
Olopatadine—Nausea—Loratadine—allergic rhinitis	5.47e-05	0.0013	CcSEcCtD
Olopatadine—Epistaxis—Triamcinolone—allergic rhinitis	5.46e-05	0.0013	CcSEcCtD
Olopatadine—Rash—Cetirizine—allergic rhinitis	5.46e-05	0.0013	CcSEcCtD
Olopatadine—Dermatitis—Cetirizine—allergic rhinitis	5.46e-05	0.0013	CcSEcCtD
Olopatadine—Visual impairment—Prednisolone—allergic rhinitis	5.45e-05	0.0013	CcSEcCtD
Olopatadine—Headache—Cetirizine—allergic rhinitis	5.43e-05	0.00129	CcSEcCtD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	5.42e-05	0.0141	CbGpPWpGaD
Olopatadine—Vomiting—Flunisolide—allergic rhinitis	5.41e-05	0.00129	CcSEcCtD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—NFKB1—allergic rhinitis	5.38e-05	0.014	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	5.37e-05	0.014	CbGpPWpGaD
Olopatadine—Rash—Flunisolide—allergic rhinitis	5.37e-05	0.00128	CcSEcCtD
Olopatadine—Dermatitis—Flunisolide—allergic rhinitis	5.36e-05	0.00128	CcSEcCtD
Olopatadine—Weight increased—Dexamethasone—allergic rhinitis	5.36e-05	0.00128	CcSEcCtD
Olopatadine—Weight increased—Betamethasone—allergic rhinitis	5.36e-05	0.00128	CcSEcCtD
Olopatadine—Hypersensitivity—Montelukast—allergic rhinitis	5.35e-05	0.00127	CcSEcCtD
Olopatadine—Headache—Flunisolide—allergic rhinitis	5.33e-05	0.00127	CcSEcCtD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	5.27e-05	0.0137	CbGpPWpGaD
Olopatadine—Rhinitis—Triamcinolone—allergic rhinitis	5.21e-05	0.00124	CcSEcCtD
Olopatadine—Asthenia—Montelukast—allergic rhinitis	5.21e-05	0.00124	CcSEcCtD
Olopatadine—Rhinitis—Methylprednisolone—allergic rhinitis	5.2e-05	0.00124	CcSEcCtD
Olopatadine—Pharyngitis—Triamcinolone—allergic rhinitis	5.16e-05	0.00123	CcSEcCtD
Olopatadine—Eye disorder—Hydrocortisone—allergic rhinitis	5.16e-05	0.00123	CcSEcCtD
Olopatadine—Nausea—Cetirizine—allergic rhinitis	5.14e-05	0.00122	CcSEcCtD
Olopatadine—Pruritus—Montelukast—allergic rhinitis	5.14e-05	0.00122	CcSEcCtD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	5.13e-05	0.0134	CbGpPWpGaD
Olopatadine—Conjunctivitis—Betamethasone—allergic rhinitis	5.11e-05	0.00121	CcSEcCtD
Olopatadine—Conjunctivitis—Dexamethasone—allergic rhinitis	5.11e-05	0.00121	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	5.09e-05	0.0133	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	5.08e-05	0.0132	CbGpPWpGaD
Olopatadine—Nausea—Flunisolide—allergic rhinitis	5.06e-05	0.0012	CcSEcCtD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	5e-05	0.013	CbGpPWpGaD
Olopatadine—Visual impairment—Methylprednisolone—allergic rhinitis	5e-05	0.00119	CcSEcCtD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	4.99e-05	0.013	CbGpPWpGaD
Olopatadine—Immune system disorder—Hydrocortisone—allergic rhinitis	4.99e-05	0.00119	CcSEcCtD
Olopatadine—Diarrhoea—Montelukast—allergic rhinitis	4.97e-05	0.00118	CcSEcCtD
Olopatadine—Erythema—Prednisolone—allergic rhinitis	4.92e-05	0.00117	CcSEcCtD
Olopatadine—Eye disorder—Methylprednisolone—allergic rhinitis	4.85e-05	0.00115	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	4.81e-05	0.0125	CbGpPWpGaD
Olopatadine—Erythema—Hydrocortisone—allergic rhinitis	4.8e-05	0.00114	CcSEcCtD
Olopatadine—Dizziness—Montelukast—allergic rhinitis	4.8e-05	0.00114	CcSEcCtD
Olopatadine—S100A12—MyD88-independent cascade—NFKB1—allergic rhinitis	4.8e-05	0.0125	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	4.73e-05	0.0123	CbGpPWpGaD
Olopatadine—Immune system disorder—Methylprednisolone—allergic rhinitis	4.68e-05	0.00111	CcSEcCtD
Olopatadine—Mediastinal disorder—Methylprednisolone—allergic rhinitis	4.67e-05	0.00111	CcSEcCtD
Olopatadine—Vision blurred—Prednisolone—allergic rhinitis	4.64e-05	0.0011	CcSEcCtD
Olopatadine—Vomiting—Montelukast—allergic rhinitis	4.62e-05	0.0011	CcSEcCtD
Olopatadine—Rash—Montelukast—allergic rhinitis	4.58e-05	0.00109	CcSEcCtD
Olopatadine—Dermatitis—Montelukast—allergic rhinitis	4.57e-05	0.00109	CcSEcCtD
Olopatadine—Ill-defined disorder—Prednisolone—allergic rhinitis	4.56e-05	0.00109	CcSEcCtD
Olopatadine—Headache—Montelukast—allergic rhinitis	4.55e-05	0.00108	CcSEcCtD
Olopatadine—Visual impairment—Betamethasone—allergic rhinitis	4.54e-05	0.00108	CcSEcCtD
Olopatadine—Visual impairment—Dexamethasone—allergic rhinitis	4.54e-05	0.00108	CcSEcCtD
Olopatadine—S100B—MyD88-independent cascade—NFKB1—allergic rhinitis	4.54e-05	0.0118	CbGpPWpGaD
Olopatadine—Erythema—Triamcinolone—allergic rhinitis	4.52e-05	0.00108	CcSEcCtD
Olopatadine—Erythema—Methylprednisolone—allergic rhinitis	4.51e-05	0.00107	CcSEcCtD
Olopatadine—Ill-defined disorder—Hydrocortisone—allergic rhinitis	4.46e-05	0.00106	CcSEcCtD
Olopatadine—Malaise—Prednisolone—allergic rhinitis	4.44e-05	0.00106	CcSEcCtD
Olopatadine—Dysgeusia—Triamcinolone—allergic rhinitis	4.43e-05	0.00105	CcSEcCtD
Olopatadine—Eye disorder—Dexamethasone—allergic rhinitis	4.41e-05	0.00105	CcSEcCtD
Olopatadine—Eye disorder—Betamethasone—allergic rhinitis	4.41e-05	0.00105	CcSEcCtD
Olopatadine—S100A12—Immune System—MS4A2—allergic rhinitis	4.38e-05	0.0114	CbGpPWpGaD
Olopatadine—Back pain—Triamcinolone—allergic rhinitis	4.38e-05	0.00104	CcSEcCtD
Olopatadine—Malaise—Hydrocortisone—allergic rhinitis	4.33e-05	0.00103	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—NFKB1—allergic rhinitis	4.32e-05	0.0112	CbGpPWpGaD
Olopatadine—Nausea—Montelukast—allergic rhinitis	4.31e-05	0.00103	CcSEcCtD
Olopatadine—Ill-defined disorder—Triamcinolone—allergic rhinitis	4.2e-05	0.000998	CcSEcCtD
Olopatadine—Ill-defined disorder—Methylprednisolone—allergic rhinitis	4.19e-05	0.000996	CcSEcCtD
Olopatadine—S100B—Immune System—MS4A2—allergic rhinitis	4.14e-05	0.0108	CbGpPWpGaD
Olopatadine—Discomfort—Prednisolone—allergic rhinitis	4.14e-05	0.000984	CcSEcCtD
Olopatadine—Erythema—Dexamethasone—allergic rhinitis	4.11e-05	0.000976	CcSEcCtD
Olopatadine—Erythema—Betamethasone—allergic rhinitis	4.11e-05	0.000976	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—IL4—allergic rhinitis	4.09e-05	0.0107	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—NFKB1—allergic rhinitis	4.08e-05	0.0106	CbGpPWpGaD
Olopatadine—Malaise—Triamcinolone—allergic rhinitis	4.08e-05	0.00097	CcSEcCtD
Olopatadine—Malaise—Methylprednisolone—allergic rhinitis	4.07e-05	0.000968	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	4.06e-05	0.000966	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	4.06e-05	0.0106	CbGpPWpGaD
Olopatadine—Discomfort—Hydrocortisone—allergic rhinitis	4.04e-05	0.000961	CcSEcCtD
Olopatadine—Oedema—Prednisolone—allergic rhinitis	4.02e-05	0.000955	CcSEcCtD
Olopatadine—Cough—Triamcinolone—allergic rhinitis	3.95e-05	0.000939	CcSEcCtD
Olopatadine—Oedema—Hydrocortisone—allergic rhinitis	3.92e-05	0.000933	CcSEcCtD
Olopatadine—Infection—Hydrocortisone—allergic rhinitis	3.9e-05	0.000927	CcSEcCtD
Olopatadine—Nervous system disorder—Hydrocortisone—allergic rhinitis	3.85e-05	0.000915	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	3.84e-05	0.01	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	3.82e-05	0.000908	CcSEcCtD
Olopatadine—Skin disorder—Hydrocortisone—allergic rhinitis	3.81e-05	0.000906	CcSEcCtD
Olopatadine—Ill-defined disorder—Dexamethasone—allergic rhinitis	3.81e-05	0.000906	CcSEcCtD
Olopatadine—Ill-defined disorder—Betamethasone—allergic rhinitis	3.81e-05	0.000906	CcSEcCtD
Olopatadine—Discomfort—Triamcinolone—allergic rhinitis	3.81e-05	0.000905	CcSEcCtD
Olopatadine—Discomfort—Methylprednisolone—allergic rhinitis	3.8e-05	0.000903	CcSEcCtD
Olopatadine—Dry mouth—Triamcinolone—allergic rhinitis	3.77e-05	0.000896	CcSEcCtD
Olopatadine—Malaise—Dexamethasone—allergic rhinitis	3.7e-05	0.00088	CcSEcCtD
Olopatadine—Malaise—Betamethasone—allergic rhinitis	3.7e-05	0.00088	CcSEcCtD
Olopatadine—Oedema—Triamcinolone—allergic rhinitis	3.69e-05	0.000878	CcSEcCtD
Olopatadine—Infection—Triamcinolone—allergic rhinitis	3.67e-05	0.000872	CcSEcCtD
Olopatadine—Infection—Methylprednisolone—allergic rhinitis	3.66e-05	0.000871	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	3.62e-05	0.00942	CbGpPWpGaD
Olopatadine—Nervous system disorder—Methylprednisolone—allergic rhinitis	3.61e-05	0.000859	CcSEcCtD
Olopatadine—Skin disorder—Methylprednisolone—allergic rhinitis	3.58e-05	0.000851	CcSEcCtD
Olopatadine—Discomfort—Betamethasone—allergic rhinitis	3.45e-05	0.000821	CcSEcCtD
Olopatadine—Discomfort—Dexamethasone—allergic rhinitis	3.45e-05	0.000821	CcSEcCtD
Olopatadine—Pain—Prednisolone—allergic rhinitis	3.43e-05	0.000817	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	3.42e-05	0.00891	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	3.39e-05	0.000805	CcSEcCtD
Olopatadine—Fatigue—Hydrocortisone—allergic rhinitis	3.38e-05	0.000804	CcSEcCtD
Olopatadine—Pain—Hydrocortisone—allergic rhinitis	3.35e-05	0.000798	CcSEcCtD
Olopatadine—Oedema—Betamethasone—allergic rhinitis	3.35e-05	0.000797	CcSEcCtD
Olopatadine—Oedema—Dexamethasone—allergic rhinitis	3.35e-05	0.000797	CcSEcCtD
Olopatadine—Infection—Dexamethasone—allergic rhinitis	3.33e-05	0.000792	CcSEcCtD
Olopatadine—Infection—Betamethasone—allergic rhinitis	3.33e-05	0.000792	CcSEcCtD
Olopatadine—Feeling abnormal—Prednisolone—allergic rhinitis	3.31e-05	0.000787	CcSEcCtD
Olopatadine—Dyspnoea—Triamcinolone—allergic rhinitis	3.29e-05	0.000783	CcSEcCtD
Olopatadine—Nervous system disorder—Betamethasone—allergic rhinitis	3.29e-05	0.000781	CcSEcCtD
Olopatadine—Nervous system disorder—Dexamethasone—allergic rhinitis	3.29e-05	0.000781	CcSEcCtD
Olopatadine—HRH1—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	3.26e-05	0.00851	CbGpPWpGaD
Olopatadine—Feeling abnormal—Hydrocortisone—allergic rhinitis	3.23e-05	0.000769	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	3.22e-05	0.00838	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	3.21e-05	0.000763	CcSEcCtD
Olopatadine—Fatigue—Triamcinolone—allergic rhinitis	3.18e-05	0.000757	CcSEcCtD
Olopatadine—Fatigue—Methylprednisolone—allergic rhinitis	3.18e-05	0.000755	CcSEcCtD
Olopatadine—Pain—Triamcinolone—allergic rhinitis	3.16e-05	0.000751	CcSEcCtD
Olopatadine—Abdominal pain—Hydrocortisone—allergic rhinitis	3.1e-05	0.000737	CcSEcCtD
Olopatadine—Body temperature increased—Hydrocortisone—allergic rhinitis	3.1e-05	0.000737	CcSEcCtD
Olopatadine—Feeling abnormal—Triamcinolone—allergic rhinitis	3.04e-05	0.000724	CcSEcCtD
Olopatadine—Feeling abnormal—Methylprednisolone—allergic rhinitis	3.04e-05	0.000722	CcSEcCtD
Olopatadine—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	3.01e-05	0.000717	CcSEcCtD
Olopatadine—Hypersensitivity—Prednisolone—allergic rhinitis	2.96e-05	0.000704	CcSEcCtD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	2.92e-05	0.00761	CbGpPWpGaD
Olopatadine—Body temperature increased—Triamcinolone—allergic rhinitis	2.92e-05	0.000694	CcSEcCtD
Olopatadine—Abdominal pain—Methylprednisolone—allergic rhinitis	2.91e-05	0.000693	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Betamethasone—allergic rhinitis	2.89e-05	0.000688	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	2.89e-05	0.000688	CcSEcCtD
Olopatadine—Hypersensitivity—Hydrocortisone—allergic rhinitis	2.89e-05	0.000687	CcSEcCtD
Olopatadine—Fatigue—Dexamethasone—allergic rhinitis	2.89e-05	0.000687	CcSEcCtD
Olopatadine—Fatigue—Betamethasone—allergic rhinitis	2.89e-05	0.000687	CcSEcCtD
Olopatadine—Pain—Betamethasone—allergic rhinitis	2.87e-05	0.000681	CcSEcCtD
Olopatadine—Pain—Dexamethasone—allergic rhinitis	2.87e-05	0.000681	CcSEcCtD
Olopatadine—Asthenia—Hydrocortisone—allergic rhinitis	2.81e-05	0.000669	CcSEcCtD
Olopatadine—Pruritus—Hydrocortisone—allergic rhinitis	2.77e-05	0.00066	CcSEcCtD
Olopatadine—Feeling abnormal—Betamethasone—allergic rhinitis	2.76e-05	0.000657	CcSEcCtD
Olopatadine—Feeling abnormal—Dexamethasone—allergic rhinitis	2.76e-05	0.000657	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	2.76e-05	0.00718	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Betamethasone—allergic rhinitis	2.74e-05	0.000652	CcSEcCtD
Olopatadine—Gastrointestinal pain—Dexamethasone—allergic rhinitis	2.74e-05	0.000652	CcSEcCtD
Olopatadine—Hypersensitivity—Triamcinolone—allergic rhinitis	2.72e-05	0.000647	CcSEcCtD
Olopatadine—Hypersensitivity—Methylprednisolone—allergic rhinitis	2.71e-05	0.000646	CcSEcCtD
Olopatadine—Diarrhoea—Hydrocortisone—allergic rhinitis	2.68e-05	0.000638	CcSEcCtD
Olopatadine—Dizziness—Prednisolone—allergic rhinitis	2.66e-05	0.000631	CcSEcCtD
Olopatadine—Asthenia—Triamcinolone—allergic rhinitis	2.65e-05	0.00063	CcSEcCtD
Olopatadine—Abdominal pain—Betamethasone—allergic rhinitis	2.65e-05	0.00063	CcSEcCtD
Olopatadine—Abdominal pain—Dexamethasone—allergic rhinitis	2.65e-05	0.00063	CcSEcCtD
Olopatadine—Body temperature increased—Betamethasone—allergic rhinitis	2.65e-05	0.00063	CcSEcCtD
Olopatadine—Body temperature increased—Dexamethasone—allergic rhinitis	2.65e-05	0.00063	CcSEcCtD
Olopatadine—Asthenia—Methylprednisolone—allergic rhinitis	2.64e-05	0.000629	CcSEcCtD
Olopatadine—Pruritus—Triamcinolone—allergic rhinitis	2.61e-05	0.000621	CcSEcCtD
Olopatadine—Pruritus—Methylprednisolone—allergic rhinitis	2.61e-05	0.00062	CcSEcCtD
Olopatadine—Dizziness—Hydrocortisone—allergic rhinitis	2.59e-05	0.000617	CcSEcCtD
Olopatadine—Rash—Prednisolone—allergic rhinitis	2.53e-05	0.000602	CcSEcCtD
Olopatadine—Dermatitis—Prednisolone—allergic rhinitis	2.53e-05	0.000602	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	2.52e-05	0.00658	CbGpPWpGaD
Olopatadine—Diarrhoea—Methylprednisolone—allergic rhinitis	2.52e-05	0.0006	CcSEcCtD
Olopatadine—Headache—Prednisolone—allergic rhinitis	2.52e-05	0.000598	CcSEcCtD
Olopatadine—Vomiting—Hydrocortisone—allergic rhinitis	2.49e-05	0.000593	CcSEcCtD
Olopatadine—Rash—Hydrocortisone—allergic rhinitis	2.47e-05	0.000588	CcSEcCtD
Olopatadine—Dermatitis—Hydrocortisone—allergic rhinitis	2.47e-05	0.000588	CcSEcCtD
Olopatadine—Headache—Hydrocortisone—allergic rhinitis	2.46e-05	0.000584	CcSEcCtD
Olopatadine—Dizziness—Triamcinolone—allergic rhinitis	2.44e-05	0.000581	CcSEcCtD
Olopatadine—Dizziness—Methylprednisolone—allergic rhinitis	2.44e-05	0.000579	CcSEcCtD
Olopatadine—Asthenia—Dexamethasone—allergic rhinitis	2.4e-05	0.000572	CcSEcCtD
Olopatadine—Asthenia—Betamethasone—allergic rhinitis	2.4e-05	0.000572	CcSEcCtD
Olopatadine—Nausea—Prednisolone—allergic rhinitis	2.38e-05	0.000567	CcSEcCtD
Olopatadine—Pruritus—Betamethasone—allergic rhinitis	2.37e-05	0.000564	CcSEcCtD
Olopatadine—Pruritus—Dexamethasone—allergic rhinitis	2.37e-05	0.000564	CcSEcCtD
Olopatadine—S100A12—Immune System—HLA-G—allergic rhinitis	2.37e-05	0.00616	CbGpPWpGaD
Olopatadine—Vomiting—Triamcinolone—allergic rhinitis	2.35e-05	0.000558	CcSEcCtD
Olopatadine—Vomiting—Methylprednisolone—allergic rhinitis	2.34e-05	0.000557	CcSEcCtD
Olopatadine—Nausea—Hydrocortisone—allergic rhinitis	2.33e-05	0.000554	CcSEcCtD
Olopatadine—Rash—Triamcinolone—allergic rhinitis	2.33e-05	0.000554	CcSEcCtD
Olopatadine—Dermatitis—Triamcinolone—allergic rhinitis	2.33e-05	0.000553	CcSEcCtD
Olopatadine—Rash—Methylprednisolone—allergic rhinitis	2.32e-05	0.000552	CcSEcCtD
Olopatadine—Dermatitis—Methylprednisolone—allergic rhinitis	2.32e-05	0.000552	CcSEcCtD
Olopatadine—Headache—Triamcinolone—allergic rhinitis	2.31e-05	0.00055	CcSEcCtD
Olopatadine—Headache—Methylprednisolone—allergic rhinitis	2.31e-05	0.000549	CcSEcCtD
Olopatadine—Diarrhoea—Betamethasone—allergic rhinitis	2.29e-05	0.000545	CcSEcCtD
Olopatadine—Diarrhoea—Dexamethasone—allergic rhinitis	2.29e-05	0.000545	CcSEcCtD
Olopatadine—HRH1—G alpha (q) signalling events—TAC1—allergic rhinitis	2.29e-05	0.00597	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTGDR2—allergic rhinitis	2.28e-05	0.00593	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-G—allergic rhinitis	2.24e-05	0.00583	CbGpPWpGaD
Olopatadine—Dizziness—Dexamethasone—allergic rhinitis	2.22e-05	0.000527	CcSEcCtD
Olopatadine—Dizziness—Betamethasone—allergic rhinitis	2.22e-05	0.000527	CcSEcCtD
Olopatadine—Nausea—Triamcinolone—allergic rhinitis	2.19e-05	0.000522	CcSEcCtD
Olopatadine—Nausea—Methylprednisolone—allergic rhinitis	2.19e-05	0.00052	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	2.16e-05	0.00563	CbGpPWpGaD
Olopatadine—Vomiting—Dexamethasone—allergic rhinitis	2.13e-05	0.000507	CcSEcCtD
Olopatadine—Vomiting—Betamethasone—allergic rhinitis	2.13e-05	0.000507	CcSEcCtD
Olopatadine—Rash—Betamethasone—allergic rhinitis	2.11e-05	0.000502	CcSEcCtD
Olopatadine—Rash—Dexamethasone—allergic rhinitis	2.11e-05	0.000502	CcSEcCtD
Olopatadine—Dermatitis—Dexamethasone—allergic rhinitis	2.11e-05	0.000502	CcSEcCtD
Olopatadine—Dermatitis—Betamethasone—allergic rhinitis	2.11e-05	0.000502	CcSEcCtD
Olopatadine—Headache—Betamethasone—allergic rhinitis	2.1e-05	0.000499	CcSEcCtD
Olopatadine—Headache—Dexamethasone—allergic rhinitis	2.1e-05	0.000499	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—PTGDR2—allergic rhinitis	2.1e-05	0.00547	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	2.09e-05	0.00544	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—NFKB1—allergic rhinitis	2.06e-05	0.00536	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	2.05e-05	0.00534	CbGpPWpGaD
Olopatadine—Nausea—Betamethasone—allergic rhinitis	1.99e-05	0.000473	CcSEcCtD
Olopatadine—Nausea—Dexamethasone—allergic rhinitis	1.99e-05	0.000473	CcSEcCtD
Olopatadine—S100A12—Immune System—IL5—allergic rhinitis	1.91e-05	0.00497	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL5—allergic rhinitis	1.8e-05	0.0047	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CYSLTR1—allergic rhinitis	1.79e-05	0.00466	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL11—allergic rhinitis	1.73e-05	0.0045	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.65e-05	0.00429	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCL11—allergic rhinitis	1.59e-05	0.00414	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.52e-05	0.00395	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DQB1—allergic rhinitis	1.48e-05	0.00385	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DQB1—allergic rhinitis	1.4e-05	0.00364	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CD4—allergic rhinitis	1.36e-05	0.00354	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CD4—allergic rhinitis	1.29e-05	0.00335	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TAC1—allergic rhinitis	1.25e-05	0.00327	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PTGDR2—allergic rhinitis	1.19e-05	0.00309	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—NFKB1—allergic rhinitis	1.17e-05	0.00305	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL5—allergic rhinitis	1.17e-05	0.00304	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—TAC1—allergic rhinitis	1.16e-05	0.00301	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—NFKB1—allergic rhinitis	1.11e-05	0.00289	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ICAM1—allergic rhinitis	1.08e-05	0.00281	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PTGDR2—allergic rhinitis	1.08e-05	0.00281	CbGpPWpGaD
Olopatadine—S100B—Immune System—ICAM1—allergic rhinitis	1.02e-05	0.00266	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	9.3e-06	0.00242	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CYSLTR1—allergic rhinitis	8.45e-06	0.0022	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SMAD3—allergic rhinitis	8.21e-06	0.00214	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL11—allergic rhinitis	8.16e-06	0.00213	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD4—allergic rhinitis	7.92e-06	0.00206	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD4—allergic rhinitis	7.49e-06	0.00195	CbGpPWpGaD
Olopatadine—S100A12—Immune System—NFKB1—allergic rhinitis	6.82e-06	0.00178	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—TAC1—allergic rhinitis	6.53e-06	0.0017	CbGpPWpGaD
Olopatadine—S100B—Immune System—NFKB1—allergic rhinitis	6.45e-06	0.00168	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTGDR2—allergic rhinitis	6.36e-06	0.00166	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL5—allergic rhinitis	6.07e-06	0.00158	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—TAC1—allergic rhinitis	5.93e-06	0.00154	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL5—allergic rhinitis	5.51e-06	0.00144	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CYSLTR1—allergic rhinitis	4.99e-06	0.0013	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL11—allergic rhinitis	4.82e-06	0.00126	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NFKB1—allergic rhinitis	4.17e-06	0.00109	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TAC1—allergic rhinitis	3.5e-06	0.000913	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—allergic rhinitis	3.47e-06	0.000905	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL5—allergic rhinitis	3.26e-06	0.000848	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SMAD3—allergic rhinitis	2.29e-06	0.000597	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NFKB1—allergic rhinitis	1.16e-06	0.000304	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—allergic rhinitis	9.7e-07	0.000253	CbGpPWpGaD
